GOECP
@goecp1
Followers
529
Following
318
Media
50
Statuses
2K
Twitter oficial del Grupo Oncológico para el Estudio del Cáncer de Pulmón. #lcsm #radonc
Spain
Joined June 2019
RT @_ShankarSiva: #SABR2025 registrations are open #radonc!! - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th….
sabrsymposium.com
Peter MacCallum Cancer Centre has been running highly successful symposia on Stereotactic Ablative Body Radiation Therapy (SABR) since 2014. In November we will once again host the SABR Symposium in...
0
24
0
RT @HenningWillers: 📢Important preclinical work in @Advances_ASTRO supporting clinical observations that proton sensitivity of normal tissu….
advancesradonc.org
To determine the relative biological effectiveness (RBE) in the rat spinal cord after 6 fractions of protons as a function of linear energy transfer (LET) and dose.
0
7
0
RT @OncoAlert: News From Industry/ FLAURA2 Update.Source AstraZeneca . . Long-term follow-up from the Phase III FLA….
0
19
0
RT @FelixEhretMD: Treating adrenal gland metastases with SBRT? Check out our latest guide - huge thanks to all collaborators! @ASTRO_org @E….
practicalradonc.org
Adrenal metastases are frequently diagnosed in patients with common solid tumors. Surgical adrenalectomy has historically been used for their management. However, stereotactic body radiotherapy...
0
31
0
RT @FuenteApolo: American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on #Reirradiation for NSCLC Executive….
0
11
0
RT @DrewMoghanaki: It's not only humans that struggle to confirm whether surgery or SBRT is a better treatment for stage I NSCLC. Even AI-b….
0
12
0
RT @DrewMoghanaki: The targeted radiation therapy market is ready for us. What are we waiting for? @SameerKeoleMD.
0
5
0
RT @IASLC: .@IyengarPuneeth and @EChrisDee discuss the potential benefits and barriers to adopting hypofractionated radiation therapy. Lea….
ilcn.org
Drs. Puneeth Iyengar and Edward Christopher Dee discuss the potential clinical and environmental benefits of hypofractionated radiation therapy, along with the barriers to broader adoption.
0
10
0
RT @gminniti2012: Happy to introduce something different from classical curative or palliative radiotherapy: Strategic radiotherapy: a new….
0
39
0
RT @SEOR_ESP: 🥈La Plataforma de Pacientes de @seor_esp ha obtenido el 2º Premio Afectivo Efectivo 25 @JNJInnovMedES en la categoría Iniciat….
0
8
0
RT @StephenVLiu: Just in time for the new academic year - 50 years of progress in NSCLC in this review article @JTOonline led by @DrJNaidoo….
jto.org
0
17
0
RT @Advances_ASTRO: 🩸ctDNA in NSCLC receiving CRT: A Prospective Study🩸. n=25.👉 76% had >/= 1 genomic alteration, most common driver mut= K….
0
3
0
RT @Advances_ASTRO: In NSCLC, how does length of esophagus receiving ☢️impact patient-reported dysphagia?. -Every 0.5cm 🔼 in 60 Gy to parti….
0
2
0
RT @Tony_Calles: 💨🧬🫁 The mutagenic forces shaping the genomes of lung cancer in never smokers. #LCSM
nature.com
Nature - An analysis of data from the Sherlock-Lung study provides insight into the mutational processes that contribute to lung cancer in never smokers, and looks at the possible role of factors...
0
14
0
Diagnosis and treatment of radiation induced pneumonitis in patients with lung cancer: An ESTRO clinical practice guideline - Radiotherapy and Oncology
thegreenjournal.com
Radiation pneumonitis (RP) was first described as a side effect of thoracic radiotherapy (RT) as early as 1896 [1]. RP proved to be a dose-limiting and potentially fatal complication, which lead to...
0
1
1
Stereotactic reirradiation for in-field lung cancer recurrence after stereotactic ablative radiotherapy: A systematic review and meta-analysis - Radiotherapy and Oncology
thegreenjournal.com
Recurrence of lung cancer remains a therapeutic challenge after high-dose thoracic radiation. Stereotactic ablative radiotherapy (SABR) offers excellent local control for early-stage non-small cell...
0
2
1